Web16 Jan 2008 · Serenex, Inc. Information provided by: Esanex Inc. Study Details ; Tabular View; No Results Posted; Disclaimer; How to Read a Study Record; Study Description. ... Inc. ClinicalTrials.gov Identifier: NCT00595686 Other Study ID Numbers: B1311002 SNX-5422-CLN1-002 : First Posted: January 16, 2008 Key Record Dates: Last Update Posted: May 17, … WebSerenex, Inc. Address: Suite A 323 Foster Street Durham DE 27701: Legal Entity Type: Corporation: Legal Entity State: DE : Documents. Click the blue "Refresh" button to load …
Serenex - Products, Competitors, Financials, Employees, …
Web3 Mar 2008 · Serenex, Inc. 323 Foster Street, Durham, North Carolina 27701 United States, (919) 281-6001 www.serenex.com Profile Investors (1) Analytics Serenex, Inc., is a proteomics based drug discovery company. Develops proprietary human therapeutics that have improved likelihoods of clinical and economic success. Company Summary SECTOR … Web4 Jan 2011 · Recombinant human fibroblast growth factor-3 (FGF-3) was purchased from R&D Systems. SNX-2112 (for chemical structure see Supplementary Fig. S1) and SNX-5542 were obtained from Serenex, Inc. SNX-2112 was dissolved in dimethyl sulfoxide (DMSO) for in vitro studies, whereas SNX-5542 was formulated in 5% dextrose in water for in vivo … dream vacations realistic goals
Steven E. Hall, Venture Partner, Lilly Ventures - Topio Networks
WebSuviCa, Inc. Oct 2012 - Nov 2024 8 years 2 months. Boulder, CO Sr. Director, Nonclinical Development and Clinical Pharmacology ... Serenex Dec 2003 - Sep 2005 1 year 10 … Web3 Mar 2008 · Serenex, Inc. 323 Foster Street, Durham, North Carolina 27701 United States, (919) 281-6001 www.serenex.com. Profile Investors (1) Analytics Serenex, Inc., is a … Web7 Jun 2024 · Serenex is a lipophilic, long-acting benzodiazepine and with sedative, hypnotic, anxiolytic and skeletal muscle relaxant properties. It does not possess any antidepressant … england v wales 2022 when